Gender Male
Mark Daly is a co-founder of Maze Therapeutics. He is also a co-director of the Program in Medical and Population Genetics at the Broad Institute, founding chief of the Analytic and Translational Genetics Unit at Massachusetts General Hospital, and director of the Institute for Molecular Medicine Finland.
